Chronic Kidney Disease: Difference between revisions

No edit summary
No edit summary
Line 10: Line 10:
[[File:Kidney anatomy.jpg|right|frameless|471x471px]]
[[File:Kidney anatomy.jpg|right|frameless|471x471px]]
Chronic kidney disease (CKD):
Chronic kidney disease (CKD):
* A progressive loss of glomerular function caused by a long-standing renal parenchymal disease. It is present when the glomerular filtration rate (GFR) is less than 60 ml/min/1.73 m2 for three consecutive months or greater than or equal to this value in patients with a kidney damage that is present for three or more months.<ref>Radiopedia [https://radiopaedia.org/articles/chronic-kidney-disease CKD] Available from:https://radiopaedia.org/articles/chronic-kidney-disease (last accessed 20.10.20)</ref>
* A progressive loss of glomerular function caused by a long-standing renal parenchymal disease. It is present when the glomerular filtration rate (GFR) is less than 60 ml/min/1.73 m2 for three consecutive months or greater than or equal to this value in patients with a kidney damage that is present for three or more months.<ref name=":0">Radiopedia [https://radiopaedia.org/articles/chronic-kidney-disease CKD] Available from:https://radiopaedia.org/articles/chronic-kidney-disease (last accessed 20.10.20)</ref>
* A non-communicable disease usually caused by diabetes and hypertension<ref>Cockwell P, Fisher LA. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32977-0/fulltext The global burden of chronic kidney disease]. The Lancet. 2020 Feb 29;395(10225):662-4.Available from:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32977-0/fulltext (last accessed 20.10.2020)</ref>
* A [[Non-Communicable Diseases|non-communicable disease]] usually caused by [[diabetes]] and hypertension<ref name=":1">Cockwell P, Fisher LA. [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32977-0/fulltext The global burden of chronic kidney disease]. The Lancet. 2020 Feb 29;395(10225):662-4.Available from:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32977-0/fulltext (last accessed 20.10.2020)</ref>
* Often involves a progressive loss of kidney function necessitating renal replacement therapy (dialysis or transplantation). When a patient needs renal replacement therapy, the condition is called end-stage renal disease (ESRD)<ref>Radiopedia [https://www.ncbi.nlm.nih.gov/books/NBK519012/ Kidney Failure] Available from:https://www.ncbi.nlm.nih.gov/books/NBK519012/ (last accessed 20.10.2020)</ref>.
* Often involves a progressive loss of kidney function necessitating renal replacement therapy ([[Dialysis Case Study|dialysis]] or transplantation). When a patient needs renal replacement therapy, the condition is called end-stage renal disease (ESRD)<ref>Radiopedia [https://www.ncbi.nlm.nih.gov/books/NBK519012/ Kidney Failure] Available from:https://www.ncbi.nlm.nih.gov/books/NBK519012/ (last accessed 20.10.2020)</ref>.


== Function ==
== Function ==
Line 26: Line 26:
* [[Blood Tests|Blood urea nitrogen (BUN) (urea in the UK)]]
* [[Blood Tests|Blood urea nitrogen (BUN) (urea in the UK)]]
* [[Blood Tests|Creatinine lev]]<nowiki/>els<ref>Radiopedia [https://radiopaedia.org/articles/kidneys Kidneys] Available from:https://radiopaedia.org/articles/kidneys (last accessed 20.10.2020)</ref>
* [[Blood Tests|Creatinine lev]]<nowiki/>els<ref>Radiopedia [https://radiopaedia.org/articles/kidneys Kidneys] Available from:https://radiopaedia.org/articles/kidneys (last accessed 20.10.2020)</ref>
== Epidemiology ==
CKD is a prevalent disease, affecting between 10-15% of the adult population globally<ref name=":0" />
* The true incidence and prevalence of CKD are difficult to determine because of the asymptomatic nature of early to moderate CKD.
* The prevalence of CKD is around 10% to 14% in the general population<ref>Vaidya SR, Aeddula NR. [https://www.ncbi.nlm.nih.gov/books/NBK535404/ Chronic Renal Failure]. InStatPearls [Internet] 2019 Dec 7. StatPearls Publishing.Available from:https://www.ncbi.nlm.nih.gov/books/NBK535404/ (last accessed 20.10.2020)</ref>.
* Worldwide, CKD accounted for 2,968,600 (1%) of disability-adjusted life-years and 2,546,700 (1% to 3%) of life-years lost in 2012.
* In 2017, the global prevalence of CKD was 9·1%, roughly 700 million cases.
* Since 1990, the prevalence of CKD has increased by 29·3%.
* A substantial increase was noted in age-standardised incidence of end-stage kidney disease (ESKD) treated by renal replacement therapy, with dialysis and kidney transplantation increasing by 43·1% and 34·4%, respectively.
* The global age-standardised mortality rate for CKD is not declining, unlike those for other important non-communicable diseases.<ref name=":1" />


== Sub Heading 2 ==
== Sub Heading 2 ==

Revision as of 08:01, 20 October 2020

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (20/10/2020)

Original Editor - Lucinda hampton

Top Contributors - Lucinda hampton, Bruno Serra, Vidya Acharya and Kim Jackson  

Introduction[edit | edit source]

Kidney anatomy.jpg

Chronic kidney disease (CKD):

  • A progressive loss of glomerular function caused by a long-standing renal parenchymal disease. It is present when the glomerular filtration rate (GFR) is less than 60 ml/min/1.73 m2 for three consecutive months or greater than or equal to this value in patients with a kidney damage that is present for three or more months.[1]
  • A non-communicable disease usually caused by diabetes and hypertension[2]
  • Often involves a progressive loss of kidney function necessitating renal replacement therapy (dialysis or transplantation). When a patient needs renal replacement therapy, the condition is called end-stage renal disease (ESRD)[3].

Function[edit | edit source]

Filter the blood to remove excess water, minerals, and waste products of protein metabolism, producing urine in the process

Kidneys are involved in

Renal function tests

Epidemiology[edit | edit source]

CKD is a prevalent disease, affecting between 10-15% of the adult population globally[1]

  • The true incidence and prevalence of CKD are difficult to determine because of the asymptomatic nature of early to moderate CKD.
  • The prevalence of CKD is around 10% to 14% in the general population[5].
  • Worldwide, CKD accounted for 2,968,600 (1%) of disability-adjusted life-years and 2,546,700 (1% to 3%) of life-years lost in 2012.
  • In 2017, the global prevalence of CKD was 9·1%, roughly 700 million cases.
  • Since 1990, the prevalence of CKD has increased by 29·3%.
  • A substantial increase was noted in age-standardised incidence of end-stage kidney disease (ESKD) treated by renal replacement therapy, with dialysis and kidney transplantation increasing by 43·1% and 34·4%, respectively.
  • The global age-standardised mortality rate for CKD is not declining, unlike those for other important non-communicable diseases.[2]

Sub Heading 2[edit | edit source]

Sub Heading 3[edit | edit source]

Resources[edit | edit source]

  • bulleted list
  • x

or

  1. numbered list
  2. x

References[edit | edit source]

  1. 1.0 1.1 Radiopedia CKD Available from:https://radiopaedia.org/articles/chronic-kidney-disease (last accessed 20.10.20)
  2. 2.0 2.1 Cockwell P, Fisher LA. The global burden of chronic kidney disease. The Lancet. 2020 Feb 29;395(10225):662-4.Available from:https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32977-0/fulltext (last accessed 20.10.2020)
  3. Radiopedia Kidney Failure Available from:https://www.ncbi.nlm.nih.gov/books/NBK519012/ (last accessed 20.10.2020)
  4. Radiopedia Kidneys Available from:https://radiopaedia.org/articles/kidneys (last accessed 20.10.2020)
  5. Vaidya SR, Aeddula NR. Chronic Renal Failure. InStatPearls [Internet] 2019 Dec 7. StatPearls Publishing.Available from:https://www.ncbi.nlm.nih.gov/books/NBK535404/ (last accessed 20.10.2020)